ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a leading global provider of solar tracking technology products ...
GE Aerospace's shares slid over the past month, but fellow industrial giants Caterpillar and Honeywell have gotten of to a ...
Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow patients to avoid immediate surgical intervention.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results